Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology.
Falsini B, Chiaretti A, Barone G, Piccardi M, Pierri F, Colosimo C, Lazzareschi I, Ruggiero A, Parisi V, Fadda A, Balestrazzi E, Riccardi R. Falsini B, et al. Among authors: lazzareschi i. Neurorehabil Neural Repair. 2011 Jul-Aug;25(6):512-20. doi: 10.1177/1545968310397201. Epub 2011 Mar 26. Neurorehabil Neural Repair. 2011. PMID: 21444653 Clinical Trial.
Extended coagulation profile of children with Long Covid: a prospective study.
Di Gennaro L, Valentini P, Sorrentino S, Ferretti MA, De Candia E, Basso M, Lancellotti S, De Cristofaro R, De Rose C, Mariani F, Morello R, Lazzareschi I, Sigfrid L, Munblit D, Buonsenso D. Di Gennaro L, et al. Among authors: lazzareschi i. Sci Rep. 2022 Nov 1;12(1):18392. doi: 10.1038/s41598-022-23168-y. Sci Rep. 2022. PMID: 36319840 Free PMC article.
Intrathecal chemotherapy with antineoplastic agents in children.
Ruggiero A, Conter V, Milani M, Biagi E, Lazzareschi I, Sparano P, Riccardi R. Ruggiero A, et al. Among authors: lazzareschi i. Paediatr Drugs. 2001;3(4):237-46. doi: 10.2165/00128072-200103040-00001. Paediatr Drugs. 2001. PMID: 11354696 Review.
Hypersensitivity reactions to carboplatin in children.
Lazzareschi I, Ruggiero A, Riccardi R, Attinà G, Colosimo C, Lasorella A. Lazzareschi I, et al. J Neurooncol. 2002 May;58(1):33-7. doi: 10.1023/a:1015853200090. J Neurooncol. 2002. PMID: 12160138
Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients.
Riccardi A, Mazzarella G, Cefalo G, Garrè ML, Massimino M, Barone C, Sandri A, Ridola V, Ruggiero A, Mastrangelo S, Lazzareschi I, Caldarelli M, Maira G, Madon E, Riccardi R. Riccardi A, et al. Among authors: lazzareschi i. Cancer Chemother Pharmacol. 2003 Dec;52(6):459-64. doi: 10.1007/s00280-003-0677-x. Epub 2003 Sep 16. Cancer Chemother Pharmacol. 2003. PMID: 13680160 Clinical Trial.
Phase II trial of temozolomide in children with recurrent high-grade glioma.
Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Di Rocco C, Madon E, Abate ME, Clerico A, Sandri A, Riccardi R. Ruggiero A, et al. Among authors: lazzareschi i. J Neurooncol. 2006 Mar;77(1):89-94. doi: 10.1007/s11060-005-9011-2. J Neurooncol. 2006. PMID: 16292488 Clinical Trial.
76 results